---
title: "NEFH"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# NEFH Gene"
tags: ['NEFH', 'Neurofilament', 'NeurologicalDisorders', 'CMT', 'ALS', 'Schizophrenia', 'SymptomManagement', 'Physiotherapy']
---

# NEFH Gene

NEFH gene encodes for a neurofilament protein that belongs to the intermediate filament family. Intermediate filaments play a significant role in maintaining the structural integrity of cells and tissues. The protein is expressed mostly in the central nervous system (CNS) and is involved in neurogenesis, axonal growth, and stability of axons. Mutations in NEFH gene have been associated with various neurological disorders.

## Function

The NEFH gene produces a neurofilament protein called Neurofilament Medium (NF-M). NF-M forms a part of the neurofilament subunit of the neuronal cytoskeleton. It helps in maintaining the shape and stability of neurons. It also regulates axonal caliber, axonal transport, and neuronal migration during brain development and neurogenesis.

## External IDs and aliases

- **Gene**: NEFH
- **Genomic location**: 22q12.2
- **Aliases**: p200; NFM; NF-M; NEF3; NF68

## External sites

- [HGNC]([Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7768))
- [NCBI Entrez]([Click](https://www.ncbi.nlm.nih.gov/gene/4744))
- [Ensembl]([Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000107262;r=22:30808015-30947911))
- [OMIM]([Click](https://www.omim.org/entry/162280))
- [UniProtKB/Swiss-Prot]([Click](https://www.uniprot.org/uniprot/P07197))

## AA mutation list and mutation type with dbSNP ID

- p.Glu396Lys - Missense - rs137852235
- p.Ser1363Phe - Missense - rs145421475

## Somatic SNVs/InDels with dbSNP ID

- c.144T>A - rs559670402

## Related disease

- Charcot-Marie-Tooth disease type 2CC (CMT2CC)
- Charcot-Marie-Tooth disease type 1F (CMT1F)
- Amyotrophic lateral sclerosis (ALS)
- Schizophrenia

## Treatment and prognosis

There is currently no cure for NEFH-associated disorders. Treatment options include symptom management, physiotherapy, and occupational therapy. In some cases, surgery can also provide relief. The prognosis varies depending on the severity of the disease.

## Drug response

Currently, there are no specific drugs available for the treatment of NEFH-related disorders. However, drugs used for the treatment of other neurological disorders might provide symptom relief.

## References

1. Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet. 2000 Sep;67(3):37-647. doi: 10.1086/303038. Epub 2000 Aug 1. PMID: 10903919; PMCID: PMC1287538.
2. Tatton NA. Neurofilament disorders: pathology and mechanisms. J Neuropathol Exp Neurol. 1998 Dec;57(12):1051-70. doi: 10.1097/00005072-199812000-00001. PMID: 9862634. 

## Author

- Written by: @gbalaji91
- Reviewed by: @sahil505 and @meenakshi.vijay
- DOI: N/A

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**